A phase III randomized study of nivolumab plus AVD or Brentuximab Vedotin plus AVD in patients age >=12 with newly diagnosed advanced stage classical Hodgkin Lymphoma.Read More
A phase II study of veliparib and local irradiation followed by maintenance veliparib and temozolomide in children with newly diagnosed high grade glioma (HGG).Read More
A trial testing the effects of pembrolizumab with or without chemotherapy treatment for patients 70 years of age and older with advanced non small cell lung cancer.Read More
Nulla vitae elit libero, a pharetra augue. Nulla vitae elit libero, a pharetra augue. Nulla vitae elit libero, a pharetra augue. Donec sed odio dui. Etiam porta sem malesuada.